Neurodegenerative Diseases Clinical Trials in Warsaw
2 recruitingWarsaw, Poland
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
DementiaBrain DiseasesCentral Nervous System Diseases+6 more
Eli Lilly and Company1,500 enrolled141 locationsNCT05508789
Recruiting
Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases
Multiple System AtrophyParkinson DiseaseMotor Neuron Disease+2 more
Kliniken Beelitz GmbH350 enrolled16 locationsNCT04706234